Skip to main content

BlueNalu Advances Strategic Partnership with Nutreco to Progress Cell-Cultured Seafood

Latest agreement expected to secure food-grade supply chain to support commercialization requirements

BlueNalu, a global leader in the development of cell-cultured seafood, announced today the signing of a Letter of Intent (LOI) with Nutreco, a global leader in animal nutrition and aquafeed. Building on the success of earlier collaborations, this agreement represents joint interest in the establishment and scale-up of a food-grade supply chain for cell-cultured seafood manufacturing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230313005334/en/

BlueNalu bluefin tuna suspension muscle derived cells were shown in our studies to grow equally fast in food grade and pharmaceutical grade cell culture media. In these studies, doubling times averaged <24 hours in food grade media, showing the potential of these cells for large scale manufacturing. (Graphic: Business Wire)

BlueNalu bluefin tuna suspension muscle derived cells were shown in our studies to grow equally fast in food grade and pharmaceutical grade cell culture media. In these studies, doubling times averaged <24 hours in food grade media, showing the potential of these cells for large scale manufacturing. (Graphic: Business Wire)

This LOI constitutes the third agreement between the two companies, that originated in December 2019, and coincided with the participation of Nutreco in the Series A round financing of BlueNalu. This next stage of the companies’ partnership marks the beginning of Nutreco’s food-grade supply chain infrastructure development in parallel to BlueNalu’s production phases, from pilot scale development to regulatory stages, and its subsequent commercialization activities. This collaboration includes an initial phase in which BlueNalu and Nutreco will join forces to bring down the costs of cell feed and establish specifications and metrics for certain raw materials necessary to produce BlueNalu’s proprietary cell-cultured seafood products. Importantly, these specifications must be in accordance with food-grade regulatory requirements for nations in which BlueNalu plans to market its products.

“Our vision to create a healthy, secure and sustainable protein solution with cell-cultured seafood, starts by solving several key challenge areas, which include the shift from a pharma-grade to food-grade ingredient supply,” said Lou Cooperhouse, co-founder, president and CEO at BlueNalu. “I’m proud to share that between our team’s innovation and incredible strategic partners, we’ve continued to overcome these hurdles. We are excited to strengthen our partnership with Nutreco as we aim to scale together to bring nutritious seafood products to consumers worldwide.”

“At Nutreco, it is our purpose to feed the growing global population in a safe and sustainable way, and we understand the important role cell-cultured proteins can play in addressing this global challenge,” said Joost Matthijssen, Chief Strategy Officer at Nutreco. “That is why we are pleased to invest further to support BlueNalu’s ongoing development and commercialization efforts and the cell-cultured industry at large.”

This agreement complements BlueNalu’s prior announcement regarding its large-scale commercialization plans, and its business differentiation with whole muscle product forms; a non-GMO, single-cell suspension line; and proprietary lipid-loading technology that allows for continuous production.

“Our team has achieved significant technological feats that have reinforced our pathway and support commercial viability,” said Lauran Madden, Ph.D., Chief Technology Officer at BlueNalu. “This commitment with Nutreco further enhances our technological readiness and our ability to scale and bring products to the market.” Susanne Wiegel, Ph.D., Head of Alternative Protein at Nutreco added, “We look forward to continuing our collaboration with BlueNalu in the years ahead and placing our capabilities as global leader in nutritional solutions at the service of visionary protein producers determined to drive forward the cellular agriculture industry.”

BlueNalu intends to bring a portfolio of seafood products to global markets, and its first commercial product will be the high value toro portion of bluefin tuna, which is in great demand from the foodservice sector, yet is increasingly inaccessible and associated with considerable sustainability challenges worldwide.

To learn more about BlueNalu, please visit www.bluenalu.com.

About BlueNalu

BlueNalu’s mission is to develop great-tasting, healthy, safe and trusted cell-cultured seafood products that support the sustainability and diversity of our ocean. The company has developed a robust pipeline of seafood products from a wide array of species and plans to launch its first commercial product, premium bluefin tuna toro, following regulatory approval. BlueNalu is a member of the United Nations Global Compact and aligned with the UN Sustainable Development Goals, a blueprint to achieve a better and more resilient future for our planet. BlueNalu began its operations in 2018 and is based in San Diego, California.

Forward looking statement

This press release contains forward-looking statements including, but not limited to, statements related to the scalability of BlueNalu’s products, the development and commercialization of BlueNalu’s products and the benefits of BlueNalu’s partnership with Nutreco. These forward-looking statements are based on BlueNalu’s current expectations and inherently involve significant risks and uncertainties. BlueNalu undertakes no duty or obligation to update any forward-looking statements contained in this press release as a result of new information.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.